Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation

Abstract MYC upregulation is associated with multidrug refractory disease in patients with multiple myeloma (MM). We, isolated patient-derived MM cells with high MYC expression and discovered that NCOR2 was down-regulated in these cells. NCOR2 is a transcriptional coregulatory protein and its role i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tomoaki Mori, Rakesh Verma, Rie Nakamoto-Matsubara, Ka Tat Siu, Cristina Panaroni, Keertik S. Fulzele, Kenta Mukaihara, Chukwuamaka Onyewadume, Allison Maebius, Hiroki Kato, Lai Ping Wong, Ruslan I. Sadreyev, David T. Scadden, Noopur S. Raje
Format: article
Langue:EN
Publié: Nature Publishing Group 2021
Sujets:
Accès en ligne:https://doaj.org/article/b338d530f2da4568b81bbdf194813434
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!